Patents by Inventor Todd Meyers

Todd Meyers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Validating a sample collection device
    Patent number: 11915423
    Abstract: An image of a sample collection device is captured. The image of the sample collection device is analyzed to determine whether the sample collection device includes a sufficient amount of fluid sample. The image of the sample collection device is validated based on a result of the image analysis.
    Type: Grant
    Filed: June 16, 2023
    Date of Patent: February 27, 2024
    Assignee: Everly Well, Inc.
    Inventors: Christopher Wesley Allen, Claudia Carrillo Gomez, Emma Todd LaPorte, Matthew William Meyer, Nini Luyuan Nathan, Nicholas Mattsson Parker, Jason Michael Pepas, James Joseph Vanaria
  • CHECKPOINT KINASE 1 (CHK1) INHIBITORS AND USES THEREOF
    Publication number: 20230310423
    Abstract: Provided herein are compounds and methods for the treatment of cancer. The methods include administering to a subject in need a therapeutically effective amount of a Chk1 inhibitor disclosed herein.
    Type: Application
    Filed: June 1, 2023
    Publication date: October 5, 2023
    Inventors: Anthony B. PINKERTON, Stephen Todd MEYER, Jacques MAUGER, Yen Pham Hong TRUONG, Rachelle Janette ELSDON
  • METHODS AND KITS FOR DETECTING OR DETERMINING AN AMOUNT OF AN ANTI-B-CORONAVIRUS ANTIBODY IN A SAMPLE
    Publication number: 20230258638
    Abstract: Disclosed herein are methods, kits, systems, algorithms and improvements for detecting the presence of or determining an amount, quantity, concentration and/or level of an antibody against at least one type of ?-coronavirus, such as, for example, an antibody against SARS-CoV or SARS-CoV-2, in one or more samples obtained from a subject. In some aspects, the methods, kits and systems relate to detecting the presence of or determining an amount, quantity, concentration and/or level of at least one type of anti-?-coronavirus antibody, such as an IgG and/or IgM antibody, in one or more samples obtained from a subject.
    Type: Application
    Filed: October 12, 2022
    Publication date: August 17, 2023
    Inventors: A. Scott Muerhoff, John C. Prostko, James L. Stewart, Mary A. RODGERS, Gavin A. CLOHERTY, James Hartnett, Jeff Moore, Kathy Otis, Alak Kar, Bailin Tu, Bryan Tieman, Carolyn Strobel, David Hawksworth, Robert Ziemann, Zhihong Lin, Chris Marohnic, Peter Wiebe, Todd Meyer, Weijie Jiao, Gangamani S. Beligere, Saminathan X. Muthusamy, Jessica L. Grieshaber, Sandra K. Pearce, Edwin C. Frias, Russell E. Taylor, Kelly Coller, Yangrong E. Zhang, Thomas T. Biegalski, David J. Daghfal, Claudio Galli, Sergey Y. Tetin, Qiaoqiao Ruan, Patrick MacDonald, Michael S. Cassidy, Mary E. Gardiner, Mary Ann P. Palafox, Matthew S. Matias, Melissa B. Brennan, Philip W. Schultz, Beth C. Trudeau
  • Checkpoint kinase 1 (CHK1) inhibitors and uses thereof
    Patent number: 11707462
    Abstract: Provided herein are compounds and methods for the treatment of cancer. The methods include administering to a subject in need a therapeutically effective amount of a Chk1 inhibitor disclosed herein.
    Type: Grant
    Filed: August 29, 2022
    Date of Patent: July 25, 2023
    Assignee: BOUNDLESS BIO, INC.
    Inventors: Anthony B. Pinkerton, Stephen Todd Meyer, Jacques Mauger, Yen Pham Hong Truong, Rachelle Janette Elsdon
  • Expandable bone grafts and methods of manufacture thereof
    Patent number: 11622865
    Abstract: The present invention relates to compressed bone-based products and methods to make the same. The maintained compressed state of the product serves to enhance the product's inherent osteoconductivity.
    Type: Grant
    Filed: November 3, 2020
    Date of Patent: April 11, 2023
    Assignee: Bacterin International, Inc.
    Inventors: Mark Schallenberger, Helena Lovick, Todd Meyer
  • CHECKPOINT KINASE 1 (CHK1) INHIBITORS AND USES THEREOF
    Publication number: 20230026313
    Abstract: Provided herein are compounds and methods for the treatment of cancer. The methods include administering to a subject in need a therapeutically effective amount of a Chk1 inhibitor disclosed herein.
    Type: Application
    Filed: August 29, 2022
    Publication date: January 26, 2023
    Inventors: Anthony B. PINKERTON, Stephen Todd MEYER, Jacques MAUGER, Yen Pham Hong TRUONG, Rachelle Janette ELSDON
  • SHAPED BONE FIBER-BASED PRODUCTS AND METHOD OF MANUFACTURE THEREOF
    Publication number: 20230001650
    Abstract: The present invention relates to shaped, bone fiber-based products and methods to make the same.
    Type: Application
    Filed: September 9, 2022
    Publication date: January 5, 2023
    Inventors: Todd Meyer, Helena M. Lovick, Michael Mansfield, Daniel Cox, Gregory Juda
  • Shaped bone fiber-based products and a method of manufacture thereof
    Patent number: 11446882
    Abstract: The present invention relates to shaped, bone fiber-based products and methods to make the same.
    Type: Grant
    Filed: November 26, 2018
    Date of Patent: September 20, 2022
    Assignee: Bacterin International, Inc.
    Inventors: Todd Meyer, Helena M. Lovick, Michael Mansfield, Daniel Cox, Gregory Juda
  • EXPANDABLE BONE GRAFTS AND METHODS OF MANUFACTURE THEREOF
    Publication number: 20210106435
    Abstract: The present invention relates to compressed bone-based products and methods to make the same. The maintained compressed state of the product serves to enhance the product's inherent osteoconductivity.
    Type: Application
    Filed: November 3, 2020
    Publication date: April 15, 2021
    Applicant: Bacterin International, Inc.
    Inventors: Mark Schallenberger, Helena Lovick, Todd Meyer
  • Expandable bone grafts and methods of manufacture thereof
    Patent number: 10821004
    Abstract: The present invention relates to compressed bone-based products and methods to make the same. The maintained compressed state of the product serves to enhance the product's inherent osteoconductivity.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: November 3, 2020
    Assignee: BACTERIN INTERATIONAL, INC.
    Inventors: Mark Schallenberger, Helena Lovick, Todd Meyer
  • Bone graft substitute containing a temporary contrast agent and a method of generating such and a method of use thereof
    Patent number: 10806826
    Abstract: A bone graft substitute for use in orthopedic bone grafting procedures comprising a radiolucent bone graft substitute combined with a temporary radiopaque agent. Methods of making and using the composition are also disclosed. Bone graft substitutes have become an effective means of regenerating bone in orthopedic procedures where bone loss results from surgically created defects or traumatic injury to the bone. Bone graft substitutes include mineral-based materials such as hydroxyapatite, calcium phosphates, and calcium phosphosilicates as well as allograft-derived materials and xenograft-derived materials such as collagen-based matrices and demineralized bone matrices.
    Type: Grant
    Filed: January 9, 2014
    Date of Patent: October 20, 2020
    Assignee: BACTERIN INTERNATIONAL, INC.
    Inventors: Helena Lovick, Gregory Juda, Todd Meyer
  • EFFECTOR-DEFICIENT ANTI-CD32A ANTIBODIES
    Publication number: 20190211097
    Abstract: Effector-deficient anti-CD32a monoclonal antibodies are encompassed, as are method and uses for treating CD32a-mediated diseases and disorders, including, thrombocytopenia, allergy, hemostatic disorders, immune, inflammatory, and autoimmune disorders.
    Type: Application
    Filed: November 29, 2018
    Publication date: July 11, 2019
    Inventors: John Francis, Ali Amirkhosravi, Todd Meyer, Liza Robles-Carrillo
  • SHAPED BONE FIBER-BASED PRODUCTS AND A METHOD OF MANUFACTURE THEREOF
    Publication number: 20190091942
    Abstract: The present invention relates to shaped, bone fiber-based products and methods to make the same.
    Type: Application
    Filed: November 26, 2018
    Publication date: March 28, 2019
    Inventors: Todd Meyer, Helena M. Lovick, Michael Mansfield, Daniel Cox, Gregory Juda
  • Effector-deficient anti-CD32a antibodies
    Patent number: 10184001
    Abstract: Effector-deficient anti-CD32a monoclonal antibodies are encompassed, as are method and uses for treating CD32a-mediated diseases and disorders, including, thrombocytopenia, allergy, hemostatic disorders, immune, inflammatory, and autoimmune disorders.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: January 22, 2019
    Assignee: Adventist Health System/Sunbelt Inc.
    Inventors: John Francis, Ali Amirkhosravi, Todd Meyer, Liza Robles-Carrillo
  • Shaped fiber-based products and method of manufacture thereof
    Patent number: 10173375
    Abstract: The present invention relates to shaped, bone fiber-based products and methods to make the same.
    Type: Grant
    Filed: March 5, 2015
    Date of Patent: January 8, 2019
    Assignee: BACTERIN INTERNATIONAL, INC.
    Inventors: Todd Meyer, Helena M. Lovick, Michael Mansfield, Daniel Cox, Gregory Juda
  • 3-aryl-2H-pyrazolo[4,3-b]pyridine compounds and their use as AMPA receptor modulators
    Patent number: 10100045
    Abstract: Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts, N-oxides, or solvates thereof, Also provided herein are pharmaceutical compositions comprising compounds of Formula (I) and methods of using compounds of Formula (I).
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: October 16, 2018
    Assignee: Janssen Pharmaceutica NV
    Inventors: Michael K. Ameriks, Brian Ngo Laforteza, Brad M. Savall, Warren Stanfield Wade, Stephen Todd Meyer, Márió Gyuris
  • Fused bicylic pyridine compounds and their use as AMPA receptor modulators
    Patent number: 10087185
    Abstract: Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts, N-oxides, or solvates thereof, Also provided herein are pharmaceutical compositions comprising compounds of Formula (I) and methods of using compounds of Formula (I).
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: October 2, 2018
    Assignee: Janssen Pharmaceutica NV
    Inventors: Michael K. Ameriks, Márió Gyuris, Brian Ngo Laforteza, Terry Patrick Lebold, Stephen Todd Meyer, Suchitra Ravula, Brad M. Savall, Brock T. Shireman, Warren Stanfield Wade, János Gerencsér
  • 3-ARYL-2H-PYRAZOLO[4,3-b]PYRIDINE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS
    Publication number: 20180111925
    Abstract: Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts, N-oxides, or solvates thereof, Also provided herein are pharmaceutical compositions comprising compounds of Formula (I) and methods of using compounds of Formula (I).
    Type: Application
    Filed: October 23, 2017
    Publication date: April 26, 2018
    Applicant: Janssen Pharmaceutica NV
    Inventors: Michael K. Ameriks, Brian Ngo Laforteza, Brad M. Savall, Warren Stanfield Wade, Stephen Todd Meyer, Márió Gyuris
  • FUSED BICYLIC PYRIDINE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS
    Publication number: 20180111933
    Abstract: Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts, N-oxides, or solvates thereof, Also provided herein are pharmaceutical compositions comprising compounds of Formula (I) and methods of using compounds of Formula (I).
    Type: Application
    Filed: October 23, 2017
    Publication date: April 26, 2018
    Applicant: Janssen Pharmaceutica NV
    Inventors: Michael K. Ameriks, Márió Gyuris, Brian Ngo Laforteza, Terry Patrick Lebold, Stephen Todd Meyer, Suchitra Ravula, Brad M. Savall, Brock T. Shireman, Warren Stanfield Wade, János Gerencsér
  • Vehicle front bumper cover
    Patent number: D1015965
    Type: Grant
    Filed: November 23, 2021
    Date of Patent: February 27, 2024
    Assignee: Ford Global Technologies, LLC
    Inventors: Todd Willing, Paul Wraith, Dong H. Park, Anthony Meyer, Martin B. Coons